Does the product work and address real needs----Yes
Do we have real patient proof of concept--------Yes
Is this a better alternative treatment to the current standard of care--------------------------------Absolutely
Is there insurance company benefits to this-----guaranteed
We now know we got a whopper of a product that can sell volumes in the billions with literally no competition but lets look at the parameters:
we have 16 employees and we need to execute this as soon as humanly possible.
The DVEous graph of a few posts ago shows that in 2004 the world knew this was the magic bullet----what the world learned as the stock went down was the previous management blew it and the graph shows a long aimless walk in the wilderness was to follow,
Yesterdays scars news and this weeks press clearly show we just formally arrived---this is all about execution of trials for a product of multiple sales channel benefits.
Folks---i have that warm fuzzy feeling that we now need to count patients through trials and all the trials. If you were the CEO of the miracle product/cure i can assure you when FDA approval comes ReCell will be on an automatic reorder system in every hospital and clinic across the whole world.Count trial patients and not sales----the medical pros already know the sales will be in the billions when we get the trials completed and stop concentrating on quarterlies-----they just got out of the wilderness---Gizzard said it right ---the trajectory does call for a 10MM volume day with a 30% rise and when the professional funds are out of bullets double that the next time.Put this stock certificate in your drawer and look at it around Christmas time----DVEous------wait till you see the graph trajectory about then and we all can fill in the blanks a year later----trial trials trials----when the field is built they all will play. BD---muy bien mate!!!!
- Forums
- ASX - By Stock
- its all about executing on trials and they wil
Does the product work and address real needs----YesDo we have...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVH (ASX) to my watchlist
|
|||||
Last
$2.73 |
Change
-0.130(4.55%) |
Mkt cap ! $198.1M |
Open | High | Low | Value | Volume |
$2.77 | $2.77 | $2.70 | $316.1K | 115.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 31 | $2.73 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.74 | 5886 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2500 | 2.710 |
2 | 4913 | 2.700 |
5 | 13682 | 2.690 |
6 | 15561 | 2.680 |
3 | 9825 | 2.670 |
Price($) | Vol. | No. |
---|---|---|
2.720 | 547 | 2 |
2.730 | 2000 | 2 |
2.740 | 5820 | 2 |
2.750 | 23082 | 4 |
2.760 | 6030 | 3 |
Last trade - 10.37am 15/08/2024 (20 minute delay) ? |
Featured News
AVH (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online